PatientSky Group (Buy, TP: NOK2.20) - Cost-cuts set to materialise
We have trimmed our 2022e revenue on lower than forecast Q3 revenues, but have further accelerated our estimated opex and capex reductions on the company’s reported cost-reduction initiatives. As we expect the opex and capex reductions to drive increased profitability and mitigate any potential near-term liquidity risk, we reiterate our BUY and NOK2.2 target price.
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.